Molecular Pharmacology,
Journal Year:
2024,
Volume and Issue:
106(4), P. 155 - 163
Published: Aug. 6, 2024
The
family
of
human
G
protein-coupled
receptors
(GPCRs)
is
comprised
about
800
different
members,
with
35%
current
pharmaceutical
drugs
targeting
GPCRs.
However,
GPCR
structural
biology,
necessary
for
structure-guided
drug
design,
has
lagged
behind
that
other
membrane
proteins,
and
it
was
not
until
the
year
2000
when
first
crystal
structure
a
(rhodopsin)
solved.
Starting
in
2007,
determination
additional
structures
facilitated
by
protein
engineering,
new
crystallization
techniques,
complexation
antibody
fragments,
strategies.
More
recently,
use
camelid
heavy-chain-only
fragments
(nanobodies)
as
crystallographic
chaperones
revolutionized
field
aiding
more
than
340
to
date.
In
most
cases,
solved
complexes
nanobodies
(Nbs)
have
revealed
binding
mode
cognate
or
non-natural
ligands;
few
same
Nb
acted
an
orthosteric
allosteric
modulator
signaling.
this
review
we
summarize
multiple
ingenious
strategies
been
conceived
implemented
last
decade
capitalize
on
discovery
study
GPCRs
from
perspective.
Significance
Statement
are
major
pharmacological
targets,
their
at
high
resolution
essential
design
insights
functions.
Single
domain
antibodies
greatly
GPCRs,
forming
directly
indirectly
through
partners.
Communications Biology,
Journal Year:
2024,
Volume and Issue:
7(1)
Published: April 25, 2024
Abstract
G
protein-coupled
receptors
naturally
oscillate
between
inactive
and
active
states,
often
resulting
in
receptor
constitutive
activity
with
important
physiological
consequences.
Among
the
class
C
that
typically
sense
amino-acids
their
derivatives,
calcium
sensing
(CaSR)
tightly
controls
blood
levels.
Its
has
not
yet
been
studied.
Here,
we
demonstrate
importance
of
inter-subunit
disulfide
bridges
maintaining
state
CaSR,
undetectable
activity,
unlike
other
receptors.
Deletion
these
results
strong
is
abolished
by
mutations
preventing
amino
acid
binding.
It
shows
this
link
necessary
to
limit
agonist
effect
acids
on
CaSR.
Furthermore,
human
genetic
deleting
associated
hypocalcemia
result
elevated
CaSR
activity.
These
highlight
fine
tuning
ACS Pharmacology & Translational Science,
Journal Year:
2024,
Volume and Issue:
7(5), P. 1557 - 1570
Published: April 25, 2024
The
calcium
sensing
receptor
(CaSR)
is
a
ubiquitously
expressed
G-protein
coupled
(GPCR)
that
regulates
extracellular
signals
via
the
parathyroid
glands.
CaSR
has
recently
also
been
implicated
in
noncalcitropic
pathophysiologies
like
asthma,
gut
inflammation,
and
cancer.
To
date,
molecular
tools
enable
bioimaging
of
tissues
are
lacking.
Based
on
silico
analyses
available
structure–activity
relationship
data
ligands,
we
designed
prepared
silicon-rhodamine
(SiR)
conjugates
clinically
approved
drug
evocalcet.
new
probes
EvoSiR4
EvoSiR6,
with
differing
linker
lengths
at
evocalcet
carboxyl
end,
both
showed
6-fold
3-fold
increase
potency
toward
(EC50
<
45
nM)
compared
to
evocalcet-linker
conjugate,
respectively,
an
FLIPR-based
cellular
functional
assay.
specificity
EvoSiR
binding
impact
albumin
was
evaluated
live
cell
experiments.
Both
strong
binding,
which
facilitated
clearance
nonspecific
interactions.
Accordingly,
zebrafish
embryos,
specifically
labeled
high
expressing
neuromasts
lateral
line
vivo.
assessed
human
ex
vivo,
showing
specific
absolute
CaSR-associated
fluorescence
autofluorescence.
In
summary,
functionalization
by
SiR
led
preparation
potent
fluorescent
probes.
versatile
small-molecular
probe
can
be
employed
CaSR-related
biomedical
where
antibodies
not
applicable.
ACS Chemical Biology,
Journal Year:
2024,
Volume and Issue:
19(7), P. 1661 - 1670
Published: July 8, 2024
The
calcium-sensing
receptor
(CaSR),
abundantly
expressed
in
the
parathyroid
gland
and
kidney,
plays
a
central
role
calcium
homeostasis.
In
addition,
CaSR
exerts
multimodal
roles,
including
inflammation,
muscle
contraction,
bone
remodeling,
other
organs
tissues.
diverse
functions
of
are
mediated
by
many
endogenous
exogenous
ligands,
calcium,
amino
acids,
glutathione,
cinacalcet,
etelcalcetide,
that
have
distinct
binding
sites
CaSR.
However,
strategies
to
evaluate
ligand
interactions
with
remain
limited.
Here,
we
developed
glutathione-based
photoaffinity
probe,
DAZ-G,
analyzes
We
showed
DAZ-G
binds
acid
site
acts
as
positive
allosteric
modulator
Oxidized
reduced
glutathione
phenylalanine
effectively
compete
conjugation
CaSR,
while
etelcalcetide
cooperative
effects.
An
unexpected
finding
was
caffeine
competes
DAZ-G's
effective
concentration
for
activation
(<10
μM)
is
easily
attainable
plasma
ordinary
consumption.
Our
report
demonstrates
utility
new
chemical
probe
discovers
protein
target
caffeine,
suggesting
consumption
can
modulate
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2024,
Volume and Issue:
unknown
Published: July 8, 2024
Abstract
The
calcium-sensing
receptor
(CaSR)
is
responsible
for
sustaining
a
stable
blood
calcium
concentration.
Consequently,
genetic
and
acquired
changes
in
this
G
protein-coupled
can
give
rise
to
various
homeostasis
disorders.
Synthetic
positive
allosteric
modulators
targeting
CaSR
are
currently
used
treat
hypercalcemia,
but
their
usage
highly
limited
due
the
high
risk
of
severe
hypocalcemia
gastrointestinal
intolerance.
In
study,
we
aimed
generate
pharmacologically
active
CaSR-specific
nanobodies
that
could
be
employed
as
new
generation
pharmacological
tools
investigate
function
potentially
serve
drug
modality
effective
treatment
CaSR-related
Nanobodies
were
generated
by
immunization
llama
with
CHO
cells
recombinantly
overexpressing
myc-epitope-tagged
human
CaSR.
Following
construction
phage
display
library
representing
repertoire
nanobody
genes,
binding
isolated
FACS
whole
HEK293
HA-epitope-tagged
Based
on
sequence
comparison,
37
from
25
different
families
purified
subsequent
characterized
vitro
modulation
signaling.
screened
agonist,
well
negative
activity
cellular
assays
downstream
activation.
We
identified
eight
acting
divided
into
five
main
based
identity.
most
potent
(Nb4)
extracellular
domain
was
slightly
more
than
reference
small
molecule
PAM
NPS
R-568.
This
study
describes
discovery
characterization
modulators.
These
class
research
CaSR,
which
developed
therapeutics
Molecular Pharmacology,
Journal Year:
2024,
Volume and Issue:
106(4), P. 155 - 163
Published: Aug. 6, 2024
The
family
of
human
G
protein-coupled
receptors
(GPCRs)
is
comprised
about
800
different
members,
with
35%
current
pharmaceutical
drugs
targeting
GPCRs.
However,
GPCR
structural
biology,
necessary
for
structure-guided
drug
design,
has
lagged
behind
that
other
membrane
proteins,
and
it
was
not
until
the
year
2000
when
first
crystal
structure
a
(rhodopsin)
solved.
Starting
in
2007,
determination
additional
structures
facilitated
by
protein
engineering,
new
crystallization
techniques,
complexation
antibody
fragments,
strategies.
More
recently,
use
camelid
heavy-chain-only
fragments
(nanobodies)
as
crystallographic
chaperones
revolutionized
field
aiding
more
than
340
to
date.
In
most
cases,
solved
complexes
nanobodies
(Nbs)
have
revealed
binding
mode
cognate
or
non-natural
ligands;
few
same
Nb
acted
an
orthosteric
allosteric
modulator
signaling.
this
review
we
summarize
multiple
ingenious
strategies
been
conceived
implemented
last
decade
capitalize
on
discovery
study
GPCRs
from
perspective.
Significance
Statement
are
major
pharmacological
targets,
their
at
high
resolution
essential
design
insights
functions.
Single
domain
antibodies
greatly
GPCRs,
forming
directly
indirectly
through
partners.